Moody’s upgrades New York Methodist Hospital to ‘Baa1’

Moody’s Investors Service has upgraded Brooklyn-based New York Methodist Hospital’s rating to “Baa1” from “Baa2.”

Advertisement

The rating upgrade was based on a number of factors, including clarification on the hospital’s future capital and debt plans, an increase in investments and sustained improvement and operating margins. New York Methodist has improved operating cash flow margins to a range of 8 to 9 percent.

The positive outlook reflects the expectation that the hospital’s margins will be sustained and investments will continue to grow to support its debt load.

 More articles on hospital credit ratings:

7 recent hospital rating and outlook changes, affirmations 
Moody’s revises Texas Health Resources’ outlook to positive 
Moody’s downgrades St. Luke’s revenue bonds to ‘A3’, outlook stable 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.